Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Metastatic Castration-Resistant Prostate Cancer × inavolisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 6 Triple Negative Breast Neoplasms 2 Solid Tumors 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer 1 HER2-positive Breast Cancer 1 Colorectal Neoplasms 1

Interventions

enzalutamide 4 abiraterone 2 sapanisertib 1 onvansertib 1 inavolisib 1 abemaciclib 1 Prednisone 1 Docetaxel 1 Diagnostic Tests, Routine 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07287150 2026-03-05

InavoPC

Hoffmann-La Roche

Phase 2 Recruiting

Metastatic Castration-Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡